Zobrazeno 1 - 10
of 39
pro vyhledávání: '"B, Erdman"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Zootaxa. 4648
Classification and evolutionary relationships among anchialine shrimp from the family Barbouriidae Christoffersen, 1987, has long been a topic of debate amongst crustacean taxonomists. To date, no study has examined morphological or molecular variati
Publikováno v:
Proceedings of the Biological Society of Washington. 129:164-172
Although observations of the box jellyfish Tripedalia cystophora have been widely documented since it was first recorded in Jamaica in 1897, to date there are no published reports of its occurrence in the Gulf of Mexico. Eighteen specimens of Tripeda
Publikováno v:
Drug Safety
Background The US Food and Drug Administration (FDA) uses the Adverse Event Reporting System (FAERS) to support post-marketing safety surveillance programs. Currently, almost one million case reports are submitted to FAERS each year, making it a vast
Publikováno v:
Topics in Clinical Nutrition. 24:6-15
Autor:
Nicholas P. Tatonetti, Mo Dimbil, Keith B. Hoffman, Colin B. Erdman, Andrea Demakas, Robert F. Kyle, Brian M. Overstreet, Dingguo Chen
Publikováno v:
Journal of managed carespecialty pharmacy. 21(12)
Given the multiple limitations associated with relatively homogeneous preapproval clinical trials, inadequate data disclosures, slow reaction times from regulatory bodies, and deep-rooted bias against disclosing and publishing negative results, there
Publikováno v:
Marine Biodiversity Records. 8
Sterrer's cave shrimp (Parhippolyte sterreri) is recorded for the first time from San Salvador Island, Bahamas. A single adult specimen was collected in June 2011 with hand nets at the southern conduit mouth in Mermaid Pond, an anchialine pond on the
Publikováno v:
Proceedings of the Water Environment Federation. 2002:117-136
Publikováno v:
Drug Safety
Background The United States Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) consists of adverse event (AE) reports linked to approved drugs. The database is widely used to support post-marketing safety surveillance prog
Publikováno v:
BMJ (Clinical research ed.). 348
Anticoagulants are some of the most widely used drugs worldwide. Dabigatran is commonly assumed to be safer than warfarin, but because debate continues on this question,1 we analysed post-marketing safety signals across this drug class. Drug safety a